ctrl K

Watchlist Price Alert

Bellevue Life Sciences Ac... (BLACU)

NASDAQ: BLACU · Real-Time Price · USD

3.36

-3.74 (-52.68%)

At close: Feb 14, 2025, 3:54 PM

Bellevue Life Sciences Acquisition Income Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Revenue	n/a	n/a	n/a	n/a
Cost of Revenue	n/a	n/a	n/a	n/a
Gross Profit	n/a	n/a	n/a	n/a
Operating Income	-1.83M	-35.39K	-3.31K	-23.81K
Interest Income	n/a	n/a	n/a	n/a
Pretax Income	944.59K	-35.39K	-3.31K	-23.81K
Net Income	403.78K	-35.39K	-3.31K	-23.81K
Selling & General & Admin	1.83M	35.39K	3.31K	23.81K
Research & Development	n/a	n/a	n/a	n/a
Other Expenses	n/a	n/a	n/a	n/a
Operating Expenses	1.83M	35.39K	3.31K	23.81K
Interest Expense	n/a	n/a	n/a	n/a
Selling & Marketing Expenses	n/a	n/a	n/a	n/a
Cost & Expenses	1.83M	35.39K	3.31K	23.81K
Income Tax Expense	540.81K	-228.48K	-236.56K	-206.3K
Shares Outstanding (Basic)	5.62M	9.05M	7.93M	7.89M
Shares Outstanding (Diluted)	5.62M	9.05M	7.93M	7.89M
EPS (Basic)	0.07	-0.00	-0.00	-0.00
EPS (Diluted)	0.07	-0.00	-0.00	-0.00
EBITDA	944.59K	-35.39K	-3.31K	-23.81K
EBIT	944.59K	-35.39K	-3.31K	-23.81K
Depreciation & Amortization	2.78M	228.49K	236.56K	206.3K